Erica Mayer
, Director of · Mass General Brigham
Credentials: · · · ·
History
- Present
Breast Cancer Clinical Research · Mass General Brigham
- Present
- 1996–2000
Research
Journal of Clinical Oncology · 2017 · 1,017 citations
Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL
Nature · 1995 · 768 citations
Patient adherence and persistence with oral anticancer treatment
Review · Current Anthropology · 2009 · 466 citations
42 papers
34 papers
29 papers
25 papers
21 papers
- AW
20 papers
20 papers
18 papers
Grants
- 2013–2019
Dana Farber/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer
National Cancer Institute · P50
Project lead · $1.5M · Dana-Farber Cancer Inst
Clinical trials
- 2023–2027
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
Principal investigator · Active not recruiting · Phase 2
Dana-Farber Cancer Institute
- 2020–2029
Niraparib + Dostarlimab In BRCA Mutated Breast Cancer
Principal investigator · Active not recruiting · Phase 2
Dana-Farber Cancer Institute
- 2017–2026
Palbociclib After CDK and Endocrine Therapy (PACE)
Principal investigator · Active not recruiting · Phase 2
Dana-Farber Cancer Institute
- 2015–2028
PALbociclib CoLlaborative Adjuvant Study
Principal investigator · Active not recruiting · Phase 3
Alliance Foundation Trials, LLC.